Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript February 6, 2026
Immunovant, Inc. beats earnings expectations. Reported EPS is $-0.60951, expectations were $-0.72.
Operator: Good day, and thank you for standing by. Welcome to the Roivant Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Stephanie Lee. Please go ahead.
Stephanie...
